New AI helps lower cost of drug discoveryAustralian researchers have created a new drug discovery AI tool for decoding protein-molecule interactions without the need for rendering costly 3D structures.
Their drug discovery model called PSICHIC (PhySIcoCHemICal)…
Telstra, NTT contracted for major ICT upgrade in NSW health facilitieseHealth NSW disclosed that telecommunications companies Telstra and NTT were tapped to upgrade the wired and wireless networking infrastructure of more than 1,100 public…
Continue Reading
What You Should Know:
– The pharmaceutical and life sciences (PLS) sector is experiencing a resurgence in dealmaking activity, with a 20% increase in deal volume over the past year reported, according to PwC’s latest…
Continue Reading
What You Should Know:
– Sanofi, a global healthcare leader, and Biovac, a prominent South African biopharmaceutical company, announced a landmark partnership. This collaboration aims to establish local manufacturing of inactivated polio vaccines (IPV) in…
Continue Reading
What You Should Know:
– Innovaccer Inc., a healthcare artificial intelligence (AI) company, today announced a significant partnership with BSIM Healthcare Services.
– BSIM, dedicated to delivering high-quality care to underserved communities, will leverage Innovaccer’s AI-powered…
Continue Reading
What You Should Know:
– Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
– The multi-phase partnership focuses on developing…
Continue Reading
In the healthcare world, everyone wants to achieve better outcomes at lower costs. But this is much easier said than done, pointed out Dr. Patrick Runnels, chief medical officer at Cleveland-based University Hospitals.
“We’ve been…
Continue Reading
Map Data Dependencies and Where Data Will Reside
The next critical step is to map dependencies before beginning the actual modernization.
“Even a minor change to the functionality of a core system can have major downstream…
The discovery of patterns associated with diagnosis, prognosis, and therapy response in digital pathology images often requires intractable labeling of large quantities of histological objects. Here we release an open-source labeling tool, PatchSorter, which…
Continue Reading
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting in overdiagnosis and overtreatment of non-csPCa. Early identification…
Continue Reading
